THE start-up behind what is thought to be the world’s first mechanical bionic hand has secured funding to accelerate its prosthetics.
Based in Edinburgh, Metacarpal has been backed with the seed funding from investors including Scottish Enterprise, Oxford Technology, and the University of Strathclyde.
The start-up is thought to have created a highly functional prosthetic hand that is completely controlled and powered by body motion, without the need for electronics.
The bionic hand combines the practicality of body-powered control with the functionality of a myoelectric prosthetic including five-finger motion, variable grips and wrist positions.
To date, the majority of development in prosthetics has focused on robotic hands, with Metacarpal’s investors banking on a gap in the market for body-powered devices.
In providing an alternative, Metacarpal aims to enhance the acceptance rate of prosthetics, which could improve long-term health outcomes for individuals with limb differences.
The NHS estimates that 26-45% of upper-limb amputees choose to wear no prosthetic at all rather than using any currently available products.
The global market for upper limb prosthetics is forecasted to reach more than £909.7m by 2028.
The business was founded by University of Strathclyde product design engineering graduate Fergal Mackie in 2020 and was inspired by an accident he had in the final year of his studies.
After falling over and breaking both of his wrists, Mackie had to discover new ways to complete his daily tasks, sparking an interest in prosthetics.
With the funding boost, Metacarpal hope they will be able to finalise the product, begin manufacturing units and double its headcount to eight.
Their ultimate ambition is to change the lives of those with limb differences, while continuing the development of technology and expanding its capabilities in prosthetics.
Fergal Mackie, CEO and founder of Metacarpal, said: “Metacarpal was established to create a better quality of life for amputees.
“With the use of truly revolutionary, unique and disruptive technology, our body-powered bionic hand is raising the standard of upper-limb prosthetics.
“It is the only device to utilise reactive body-power technology giving fingers individual motion.
“The success of the seed funding round is a huge milestone for the business, which will enable us to develop our bionic into a commercially viable product with the potential to change the lives of prosthetics users.
“I cannot wait to see the impact that it has.”
